Neuro-Oncology Reviews

Volume 27 Number 21
31 July 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 21, 31 July

Shirani A, Obeidinia M, Ziafati M, Garavand J, Ramezani M, Ramezani F.
Effect of valproic acid and levetiracetam administration on the survival of glioma patients: a meta-analysis study.
Anticancer Drugs. 2025 Jul 21. doi: 10.1097/CAD.0000000000001746. PMID: 40699178. Meta-analysis˰ ˍ

Vlasiou MC.
The Role of Kinase Inhibitors in Cancer Neuroscience: Mechanisms, Therapeutic Potential, and Future Directions.
Anticancer Agents Med Chem. 2025 Jul 21. doi: 10.2174/0118715206387712250711132221. PMID: 40696545. Review˰ ˍ

Young JS, Berger MS, Lasocki A, Suwala AK, Niyazi M, Chang SM, Schnell O, Karschnia P.
Point/counterpoint: The role of re-resection in recurrent glioblastoma.
Neuro Oncol. 2025 Jul 21:noaf127. doi: 10.1093/neuonc/noaf127. PMID: 40689713. Perspective. ˍ

Beylerli O, Gareev I, Musaev E, Ilyasova T, Roumiantsev S, Chekhonin V.
Angiogenesis and Resistance Mechanisms in Glioblastoma: Targeting Alternative Vascularization Pathways to Overcome Therapy Resistance.
Curr Pharm Des. 2025 Jul 22. doi: 10.2174/0113816128367551250703122830. PMID: 40698688. Review˰ ˍ

Pinkiewicz M, Zaczyński A, Walecki J, Zawadzki M.
Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood-Brain Barrier and Blood-Tumor Barrier.
Int J Mol Sci. 2025 Jul 22;26(15):7050. doi: 10.3390/ijms26157050. PMID: 40806198. Review. ˍ

Vinueza L, Pineda S, Leon-Rojas JE.
Molecular Foundations of Neuroplasticity in Brain Tumours: From Microscopic Adaptation to Functional Reorganisation.
Int J Mol Sci. 2025 Jul 22;26(15):7049. doi: 10.3390/ijms26157049. PMID: 40806177. Review. ˍ

Lo SS, Halasz LM, Choi S, Kumthekar P, Wang TJC, Shu HK, Sloan AE, Olson JJ.
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of radiotherapy in the management of patients with diffuse low grade glioma in adults: update.
J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05074-1. PMID: 40705197. Guidelines˰ ˍ

Coates K, Nibbs RJ, Fraser AR.
Going viral: targeting glioblastoma using oncolytic viruses.
Immunother Adv. 2025 Jul 25;5(1):ltaf024. doi: 10.1093/immadv/ltaf024. PMID: 40717958. Review. ˍ

Ito K, Jinnouchi S, Kikukawa K, Okuyama C, Sugawara Y, Kawamoto M, Koyama K, Kawai Miyake K, Murakami K.
Clinical Practice Guidelines for ¹⁸F-Fluciclovine 2024 in the Japanese Society of Nuclear Medicine.
Ann Nucl Med. 2025 Jul 25. doi: 10.1007/s12149-025-02089-6. PMID: 40711749. Guidelines. ˍ

Zhang W, Zhang W, Wu H, Han X.
Harnessing innate immunity against glioblastoma microenvironment.
Front Immunol. 2025 Jul 25;16:1648601. doi: 10.3389/fimmu.2025.1648601. PMID: 40787444. Review. ˍ

Perreault S, Geurts M, Mahdi J, Schreck KC, Preusser M, Wen PY, Lim-Fat MJ, Werner JM.
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas.
Neuro Oncol. 2025 Jul 26:noaf164. doi: 10.1093/neuonc/noaf164. PMID: 40717628. Perspective. ˍ

Galldiks N, Lohmann P, Aboian M, Barajas RF Jr, Breen WG, Ivanidze J, Johnson DR, Kaufmann TJ, Kim MM, Mair MJ, Minniti G, Müther M, Nabavizadeh A, Palmer JD, Rudà R, Smits M, Tolboom N, Veldhuijzen van Zanten SEM, Veronesi MC, Werner JM, van den Bent M, Chang SM, Langen KJ, Law I, McConathy J, Mehta M, Preusser M, Short SC, Soffietti R, Vogelbaum M, Weller M, Wen PY, Tonn JC, Albert NL.
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas.
Lancet Oncol. 2025 Jul 28;26(8):e436-e447. doi: 10.1016/S1470-2045(25)00193-7. PMID: 40744043. Guidelines. ˍ

Hadiloo K, Mostanadi P, Asadzadeh A, Taremi S, Esmaeilzadeh A.
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions.
Cancer Cell Int. 2025 Jul 28;25(1):289. doi: 10.1186/s12935-025-03846-3. PMID: 40722155. Review. ˍ

Groth AJ, Khasraw M, Byrne JD, Reitman ZJ.
Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology.
NPJ Precis Oncol. 2025 Jul 29;9(1):264. doi: 10.1038/s41698-025-01059-5. PMID: 40730675. Review. ˍ